According to SNS Insider, Global Ovarian Cancer Diagnostics Market Growth is Driven by Rising Awareness, Technological Advancements in Imaging & Biomarker.Austin, Aug. 04, 2025 (GLOBE NEWSWIRE) -- ...

The OVATION-3 trial is designed to provide an early readout in HRD and BRCA1/2-mutated ovarian cancer patients, ideally leading to rapid filing and approval.

Tb-based radioimmunotherapy has a strong potential to eliminate ovarian cancer stem cells, providing a precise and lasting ...

Many patients with advanced cancer do not receive guideline-recommended biomarker testing before first-line treatment, data suggest.

A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models of ...

Investigators discuss how their findings on ovarian cancer mortality trends can guide earlier detection and prevention ...

A novel radioimmunotherapy strategy has shown compelling efficacy in eliminating ovarian cancer stem cells in preclinical ...

A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models of ...

An expert discusses how long-term safety considerations are evaluated through clinical trial data and postmarketing ...

New research defines four different immunologic subtypes of recurrent ovarian cancers and describes how those subtypes are ...

With a $1.2 million grant from the Department of Defense, a University of Houston engineer will lead a team of researchers in finding early markers for ovarian cancer.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.